Navigation Links
Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects

RIVERSIDE, Calif., Nov. 20 /PRNewswire/ -- Milk. It does a body good. And now it's doing it even better than originally thought. After years of research, scientists at OncoNutrition(TM) have discovered peptides found in cow's milk that stimulate the body's own production of antioxidants.

    To view the Multimedia News Release, go to:

While developing new cancer therapies, the chief scientist, Dr. David Tsai, discovered that these peptides, once unlocked from their larger host protein, stimulate the production of the antioxidant enzyme Super Oxide Dismutase (SOD). When SOD was first discovered in 1968, it was dubbed 'the enzyme of life,' because it's the first antioxidant mobilized by the cell for defense. Cancer sufferers, especially those undergoing chemotherapy, often have high levels of free radicals, which deplete the body of antioxidants. As a result, vital organs can be overburdened and injured due to chemotherapy treatment. With AminoAct(TM), now available through OncoNutrition(TM), chemotherapy patients have access to a functional nutritional supplement that boosts their antioxidant levels and aids recovery from the damages of chemotherapy.

Cancer Treatment Review recently published a clinical review of 19 different studies indicating that antioxidant supplements taken by cancer patients resulted in increased survival time and increased treatment response. Antioxidants mainly come from two sources, either from nutrients like Vitamin C, or through antioxidant enzymes produced by the body. "AminoAct(TM) stimulates the body to produce its own antioxidants. Because our product works from the inside out, users benefit from a dramatic increase in their antioxidant levels," stated Olof Mollstedt, OncoNutrition's CEO.

"Our studies show that AminoAct(TM) increases the antioxidant levels in blood by over 200 percent in a seven-day period, while nutrient-based antioxidants only increase levels marginally." Mr. Mollstedt continued, "Antioxidants act as a shield for healthy cells, while allowing chemotherapy to battle cancerous cells. AminoAct(TM) greatly increases the size of that shield."

Because chemotherapy attacks not only cancer cells, but all cells, oftentimes cancer patients must stop treatment due to chemotherapy side effects. However, like antibiotics, chemotherapy is most effective when given in complete cycles. "By dramatically increasing antioxidant levels, AminoAct(TM) helps patients to stay on their chemotherapy regimens, thus increasing the overall treatment impact," stated Dr. Tsai.

In addition to stimulating SOD production, AminoAct(TM) also increases the secretion of ghrelin, a stomach hormone that stimulates appetite. According to the American Cancer Society, weight loss in the main cause of death for 1 in 5 cancer patients. "Our research was focused on eradicating cancer by allowing chemotherapy to do the job it's intended to do," Dr. Tsai said. "Knowing that cancer patients often succumb to death due to weight loss, when we uncovered that AminoAct(TM) also increases ghrelin production, we were elated."

The milk-based peptides in AminoAct(TM) are unlocked through a proprietary technology, and do not have adverse effects on those who are lactose intolerant. For more information, visit, or call 951- 231-2388.

    Media Contacts:
    Chris French
    714-710-9229; 714-225-6142-C

    Helen Chen

SOURCE OncoNutrition
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Photos: SOS Childrens Villages Observes World Orphan Week, October 5-11, 2008
2. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
3. Photos: Sentara Joins 4 U.S. Hospitals in International TARGIT Breast Cancer Trial
4. Are Muramyl Peptides the Magic Bullet in Probiotics?
5. Tainted Chinese Food Ingredients First Discovered in 2005
6. Ironwood and Collaborators Present Preclinical Data Demonstrating That Cyclic GMP Alleviates Intestinal Pain
7. Recent Data Study Suggests Cortisol Could Help Alleviate Suffering for Those With Chronic Fatigue Syndrome and Fibromyalgia
8. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
9. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
10. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
11. Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 /PRNewswire/ ... --> adds "Global ... and "Investigation Report on China Repaglinide ... 2021 forecasts data and information to ... . --> ...
(Date:11/26/2015)... 26, 2015 ... "Radioimmunoassay Market by Type (Reagents & ... Academics, Clinical Diagnostic Labs), Application (Research, Clinical ... 2020" report to their offering. ... addition of the "Radioimmunoassay Market by ...
(Date:11/25/2015)...  The total global healthcare industry is expected to grow ... Latin America has the highest projected growth at ... Japan ), is second with growth projected at 11.5%. ... healthcare expenditure. In 2013-2014, total government funded healthcare was nearly ... to 41.2% in 2013-2014. In real terms, out of pocket ...
Breaking Medicine Technology:
(Date:11/27/2015)... CO (PRWEB) , ... November 27, 2015 , ... According ... cities are not changing the way that they are handling security in light of ... police and security presence in an attempt to stop an attack from reaching U.S. ...
(Date:11/27/2015)... County, CA (PRWEB) , ... November 27, 2015 , ... ... season , The company is offering customers 10% off of their purchase of lice ... any treatment at full price. According to a company spokesperson. “Finding lice is a ...
(Date:11/27/2015)... ... November 27, 2015 , ... Intellitec ... Dynamics SL User Group (MSDSLUG). Recognized as Microsoft’s official group for end users ... Dynamics SL software users, partners, industry experts and representatives. Intellitec Solutions’ membership status ...
(Date:11/27/2015)... IL (PRWEB) , ... November 27, 2015 , ... ... of the largest, most successful and prominent nonprofit healthcare organizations in the country. ... governance involvement with various organizations, and helped advance the healthcare industry as a ...
(Date:11/26/2015)... ... ... Inevitably when people think Thanksgiving, they also think Holiday sales and start ... and Cyber Monday massage chair sales to receive the best pricing on ... find the best massage chair deals, they can see all of the coupons in ...
Breaking Medicine News(10 mins):